Day One Biopharmaceuticals, Inc. (DAWN)

Last Year

25-Nov-23 -- 24-Nov-24

Time Period:

($2.52M) Net Amount

Buy:	0	--
Sell:	($2.52M)	$12.62 - $16.37

Company Sentiment

Other

Other

Insider Trading Sentiment: Sell

Sentiment Breakdown by Insider

0

(3)

2

(2)

1

(1)

11

0

1

+1

0

+2

0

+3

Two Year Chart

25-Nov-22 -- 24-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
19-Nov-24 4:36 PM View:	18-Nov-24 Option Sale ($139.42K)	Bender Jeremy Chief Executive Officer Director		Day One Biopharmaceuticals, Inc. - DAWN	(2%) 1.75M to 1.72M	0	0	--	--	Show Txns Hide Txns

19-Nov-24 4:30 PM View:	18-Nov-24 Option Sale ($34.37K)	York Charles N II COO, CFO and Secretary		Day One Biopharmaceuticals, Inc. - DAWN	(11%) 270.17K to 240.13K	0	0	--	--	Show Txns Hide Txns

21-Jun-24 7:17 PM View:	21-Jun-24 Market Sale ($131.88K)	Ramasastry Saira Director		Day One Biopharmaceuticals, Inc. - DAWN	(20%) 50.48K to 40.48K	0	($131.88K) (20%)	--	$13.19	Show Txns Hide Txns

19-Nov-24 4:32 PM View:	18-Nov-24 Option Sale ($41.81K)	Dubow Adam General Counsel		Day One Biopharmaceuticals, Inc. - DAWN	181% 11.43K to 32.16K	0	0	--	--	Show Txns Hide Txns

19-Nov-24 4:34 PM View:	18-Nov-24 Option Sale ($29.14K)	Blackman Samuel C. HEAD OF R&D		Day One Biopharmaceuticals, Inc. - DAWN	(8%) 2.24M to 2.06M	0	($2.39M) (7%)	--	$12.62 - $16.37	Show Txns Hide Txns